Titan Biotech Ltd — Dividend/Bonus, 02-01-2026: Corp. Action

The company has set a record date for the previously approved sub-division of its equity shares. Each existing equity share with a face value of ₹10 will be split into five equity shares, each having a face value of ₹2. This split aims to enhance the liquidity of the company's shares in the market, making them more accessible to a wider range of investors. Shareholders holding shares on the specified record date will be eligible for this share split.